Customize

K221432

3D-Side SA · cleared 2022-08-03 · product code QIH · Radiology

Premarket evidence — what FDA accepted

Device typesamd
source quote (p.3)
Customize for ankle arthroplasty is intended to be used as a software interface to assist in: Visualization, modification, validation of the planning of total ankle arthroplasty
Algorithmartificial intelligence including nonadaptive machine learning
source quote (p.5)
Both devices implement artificial intelligence including nonadaptive machine learning, followed by human supervision.
Adaptive (vs locked)No
source quote (p.5)
Both devices implement artificial intelligence including nonadaptive machine learning, followed by human supervision.
PCCPFDA source did not state this
Cybersecurity addressedFDA source did not state this

Validation studies (3)

Bench

sample size not stated

endpoints: segmentation validation of the Customize software

standards: FDA Guidance "Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices”

Bench

sample size not stated

endpoints: Repeatability and Reproducibility (R&R) study on the segmentation of ankle anatomies

standards: FDA Guidance "Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices”

Bench

sample size not stated

endpoints: accuracy study on 3D model generation for tibia and talus

standards: FDA Guidance "Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices”

Reported performance (0 observations)

FDA source did not state a quantitative performance metric — non-reporting is itself the signal.

Each value carries its own analysis unit and task — never compare or pool across devices. Source: 510(k) summary PDF.

Predicate network

Postmarket — what happened after clearance

0
recalls in product code, 24mo
3
MAUDE reports in code, 12mo
vs code's own 3-yr baseline
0
drift signals on this device

Recall and MAUDE counts are product-code-level (reports aren't reliably attributable to one device). Signals are descriptive observables with sources — never a judgment that the device is unsafe or drifting. Snapshot 2026-07-08.

Reimbursement — how devices like this got paid

Not yet tracked — no payment pathway indexed for this clearance (the reimbursement corpus is a growing seed set).

RIGOR™ Precedent · public FDA/CMS data · descriptive decision-support, not regulatory or reimbursement advice. Share this page: radar.healthai.com/precedent/device/K221432